Cargando…
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989998/ https://www.ncbi.nlm.nih.gov/pubmed/35393398 http://dx.doi.org/10.1038/s41408-022-00654-0 |
| _version_ | 1784683292283371520 |
|---|---|
| author | Begna, K. H. Xu, X. Gangat, N. Alkhateeb, H. Patnaik, M. M. Al-Kali, A. Elliott, M. A. Hogan, W. J. Litzow, M. R. Hook, C. C. Wolanskyj-Spinner, A. P. Mangaonkar, A. He, R. Pardanani, A. Shah, M. Ketterling, R. P. Tefferi, A. |
| author_facet | Begna, K. H. Xu, X. Gangat, N. Alkhateeb, H. Patnaik, M. M. Al-Kali, A. Elliott, M. A. Hogan, W. J. Litzow, M. R. Hook, C. C. Wolanskyj-Spinner, A. P. Mangaonkar, A. He, R. Pardanani, A. Shah, M. Ketterling, R. P. Tefferi, A. |
| author_sort | Begna, K. H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8989998 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89899982022-04-22 Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” Begna, K. H. Xu, X. Gangat, N. Alkhateeb, H. Patnaik, M. M. Al-Kali, A. Elliott, M. A. Hogan, W. J. Litzow, M. R. Hook, C. C. Wolanskyj-Spinner, A. P. Mangaonkar, A. He, R. Pardanani, A. Shah, M. Ketterling, R. P. Tefferi, A. Blood Cancer J Correspondence Nature Publishing Group UK 2022-04-07 /pmc/articles/PMC8989998/ /pubmed/35393398 http://dx.doi.org/10.1038/s41408-022-00654-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Begna, K. H. Xu, X. Gangat, N. Alkhateeb, H. Patnaik, M. M. Al-Kali, A. Elliott, M. A. Hogan, W. J. Litzow, M. R. Hook, C. C. Wolanskyj-Spinner, A. P. Mangaonkar, A. He, R. Pardanani, A. Shah, M. Ketterling, R. P. Tefferi, A. Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| title | Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| title_full | Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| title_fullStr | Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| title_full_unstemmed | Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| title_short | Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| title_sort | core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989998/ https://www.ncbi.nlm.nih.gov/pubmed/35393398 http://dx.doi.org/10.1038/s41408-022-00654-0 |
| work_keys_str_mv | AT begnakh corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT xux corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT gangatn corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT alkhateebh corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT patnaikmm corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT alkalia corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT elliottma corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT hoganwj corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT litzowmr corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT hookcc corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT wolanskyjspinnerap corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT mangaonkara corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT her corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT pardanania corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT shahm corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT ketterlingrp corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 AT tefferia corebindingfactoracutemyeloidleukemialongtermoutcomeof70patientsuniformlytreatedwith73 |